CB2 Insights 2019 Year In Review – A Message from CEO and Co-Founder Pradyum Sekar TORONTO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence driven from the...

CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia TORONTO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a leading data-driven company focused on bringing real-world evidence-driven from the...

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call CB2 Insights’ Q3 2019 preliminary unaudited revenue saw a sequential growth of approximately 29% compared to the previous quarterCompany’s Q3 preliminary Adjusted-EBITDA loss was significantly reduced...

VIVO and CB2 Insights Enter Technology and Research Partnership Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis offering, utilizing CB2 Insights’ leading technology platform Sail and research...